Pharmacokinetic/pharmacodynamic (PK/PD) modelling plays an important role in drug development, especially in the case of antibiotics where the data generated is used for dose prediction up to Phase 2 clinical trials. This enables efficient study designs and identification of optimal dosing regimens that may suppress drug resistance.
In this poster, we focus on:
mathematical modelling of in vivo and in vitro data to generate a rational design with reduced animal requirements in order to determine the pharmacodynamic driver and magnitude of antibiotic efficacy
optimisation of the clinical dose regimen in Phase 2 clinical trials
Read our poster to learn more about our research!
Sounds interesting? Enter your details below to continue reading…
Join our community
Discover the exclusive benefits on offer if you join our community.